 | |
| Clinical data | |
|---|---|
| Other names | 3,4-Methylenedioxy-N-methoxyethylamphetamine; MDMEOET; MDMEOETA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO3 |
| Molar mass | 237.299 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
MDMEOET, also known as3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-knowndrug and asubstituted amphetamine.[1] It is also theN-methoxyethyl analogue ofMDA.[1] MDMEOET was first synthesized byAlexander Shulgin.[1] In his bookPiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180mg.[1] MDMEOET produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.[1]
This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[2]
